共 73 条
[1]
Lipinski CA(2000)Drug-like properties and the causes of poor solubility and poor permeability J Pharmacol Tox Met 44 235-249
[2]
Müller RH(2012)Twenty years of drug nanocrystals: where are we, and where do we go? Eur J Pharm Biopharm 80 1-3
[3]
Keck CM(2007)When poor solubility becomes an issue: from early stage to proof of concept Eur J Pharm Sci 31 249-261
[4]
Stegemann S(2011)Bioavailability enhancement of poorly water soluble drugs- a review Int J Pharm Life Sci 2 640-650
[5]
Leveiller F(2004)The role of solid nanoparticle technology in the parenteral delivery of poorly water soluble drugs Int J Pharm 284 109-122
[6]
Franchi D(2011)Nanomedicine: novel approaches in human and veterinary therapeutics Vet Parasitol 180 47-71
[7]
De Jong H(2004)Nanosuspensions in drug delivery Nat Rev Drug Discov 3 785-796
[8]
Linden H(2011)Nanosuspension: an approach to enhance solubility of drug J Adv Pharm Technol Res 2 81-87
[9]
Atul G(1994)A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability Pharm Res 12 413-420
[10]
Susheel S(2008)Drug nanoparticles: formulating poorly water soluble compounds Toxicol Pathol 36 43-48